Filing Details
- Accession Number:
- 0001225208-10-021808
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-04 12:47:34
- Reporting Period:
- 2010-10-01
- Filing Date:
- 2010-10-04
- Accepted Time:
- 2010-10-04 12:47:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 901219 | Human Genome Sciences Inc | HGSI | In Vitro & In Vivo Diagnostic Substances (2835) | 223178468 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1346164 | Curran Simpson | 14200 Shady Grove Road Rockville MD 20850 | Sr. Vp, Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-10-01 | 22,903 | $12.56 | 48,184 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-10-01 | 22,903 | $29.79 | 25,281 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option - Right to Buy | Disposition | 2010-10-01 | 22,903 | $0.00 | 22,903 | $12.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 32,097 | 2015-01-17 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 5/3/10.
- This transaction was executed in multiple trades at prices ranging from $29.65 to $30.09. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or the security holder of the issu
- These options have vested and are exercisable.
Billionaire Hedge Funds
